Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes

[Image: see text] Autoimmune diseases and in particular type 1 diabetes rely heavily on treatments that target the symptoms rather than prevent the underlying disease. One of the barriers to better therapeutic strategies is the inability to detect and efficiently target rare autoreactive T-cell popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Artzy-Schnirman, Arbel, Abu-Shah, Enas, Chandrawati, Rona, Altman, Efrat, Yusuf, Norkhairin, Wang, Shih-Ting, Ramos, Jose, Hansel, Catherine S., Haus-Cohen, Maya, Dahan, Rony, Arif, Sefina, Dustin, Michael L., Peakman, Mark, Reiter, Yoram, Stevens, Molly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185737/
https://www.ncbi.nlm.nih.gov/pubmed/35616515
http://dx.doi.org/10.1021/acs.nanolett.2c00819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185737/
https://www.ncbi.nlm.nih.gov/pubmed/35616515
http://dx.doi.org/10.1021/acs.nanolett.2c00819

Ejemplares similares